GlassScriptPhysician profile
Vineet Mishra
NPI 1639337181
$44,324.11
in general payments reported to CMS, 2019-2025
56 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Mohs-Micrographic Surgery providers received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,969 · 2020: $459 · 2021: $302 · 2022: $1,090 · 2023: $13K · 2024: $13K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Consulting Fee: $8,825 · Food and Beverage: $6,410 · Travel and Lodging: $5,073 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,989.04 |
| Consulting Fee | $8,825.00 |
| Food and Beverage | $6,409.60 |
| Travel and Lodging | $5,073.17 |
| Education | $208.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $33,679.88 | 2019-2025 | |
| Merz North America, INC. | $2,577.78 | 2019 | |
| Abbvie INC. | $1,136.17 | 2019-2025 | |
| Janssen Biotech, INC. | $959.71 | 2019-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $547.76 | 2019-2025 | Jublia, Cabtreo, Siliq |
| Dermavant Sciences, INC. | $520.00 | 2023-2024 | Vtama |
| Genzyme Corporation | $502.38 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $352.78 | 2019-2025 | Libtayo, Dupixent |
| Galderma Laboratories, L.P. | $337.01 | 2022-2025 | Nemluvio, Aklief |
| Solta Medical, A Division of Bausch Health US, LLC | $288.17 | 2023-2024 | |
| Sun Pharmaceutical Industries INC. | $283.04 | 2020-2023 | Winlevi, Absorica Ld |
| Convatec INC. | $253.52 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $251.22 | 2022-2024 | Sotyktu |
| Incyte Corporation | $234.35 | 2022-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $223.70 | 2019-2025 | Spevigo |
Show all 56 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vineet Mishra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.